10/29/2025
On , we recognize that stroke remains a leading cause of death and disability worldwide, with about a quarter of patients being at risk of having a second stroke within five years of their first.
Through our partnership with J&J Innovative Medicine, we’re investigating new ways to prevent more strokes without significantly increasing the risk of bleeding. We’re making progress by focusing on Factor XIa (FXIa), a promising therapeutic target.
Learn more about stroke and our commitment to address the unmet needs in stroke care: https://bit.ly/43Itk4G